Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma
Journal: Journal of Clinical Investigation
Published: 2020-10-05
DOI: 10.1172/jci127916
Affiliations: 7
Go to articleJournal: Journal of Clinical Investigation
Published: 2020-10-05
DOI: 10.1172/jci127916
Affiliations: 7
Go to article